ATE508364T1 - Diagnoseverfahren für präeklampsie - Google Patents

Diagnoseverfahren für präeklampsie

Info

Publication number
ATE508364T1
ATE508364T1 AT06837479T AT06837479T ATE508364T1 AT E508364 T1 ATE508364 T1 AT E508364T1 AT 06837479 T AT06837479 T AT 06837479T AT 06837479 T AT06837479 T AT 06837479T AT E508364 T1 ATE508364 T1 AT E508364T1
Authority
AT
Austria
Prior art keywords
sbp
preeclampsia
proteinaceous
sflt
plgf
Prior art date
Application number
AT06837479T
Other languages
English (en)
Inventor
David Sogin
Donald Laird
Zhiguang Yu
Robert Doss
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37820640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE508364(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE508364T1 publication Critical patent/ATE508364T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Vehicle Body Suspensions (AREA)
  • Pressure Welding/Diffusion-Bonding (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
AT06837479T 2005-11-14 2006-11-14 Diagnoseverfahren für präeklampsie ATE508364T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73665905P 2005-11-14 2005-11-14
US11/367,126 US20070111326A1 (en) 2005-11-14 2006-03-03 Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia
PCT/US2006/044059 WO2007059065A2 (en) 2005-11-14 2006-11-14 Diagnostic method for proteinaceous binding pairs, cardiovascular conditions and preeclampsia

Publications (1)

Publication Number Publication Date
ATE508364T1 true ATE508364T1 (de) 2011-05-15

Family

ID=37820640

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06837479T ATE508364T1 (de) 2005-11-14 2006-11-14 Diagnoseverfahren für präeklampsie

Country Status (8)

Country Link
US (1) US20070111326A1 (de)
EP (1) EP1952156B1 (de)
JP (1) JP5225097B2 (de)
AT (1) ATE508364T1 (de)
CA (1) CA2629451A1 (de)
DE (1) DE602006021777D1 (de)
ES (1) ES2363609T3 (de)
WO (1) WO2007059065A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005022047A1 (de) * 2005-05-09 2006-11-30 Dade Behring Marburg Gmbh Bindungspartner des Plazentalen Wachstumsfaktors insbesondere gegen den Plazentalen Wachstumsfaktor gerichtete Antikörper, ihre Herstellung und Verwendung
US20080071151A1 (en) * 2006-06-30 2008-03-20 Sogin David C Method and Apparatus for Diagnosing Pre-eclampsia
DE602006015964D1 (de) * 2006-09-20 2010-09-16 Roche Diagnostics Gmbh Natriurethische Peptide und Plazenta-Wachstumfaktor/löslicher VEGF-Rezeptor unterscheiden zwischen mit der Plazenta verbundener Herzdysfunktion und mit Herzerkrankung verbundener Herzdysfunktion
DE102007038730A1 (de) * 2007-08-16 2009-02-19 Carl Zeiss Meditec Ag Nachweis des menschlichen Vascular Endothelial Growth Factor
EP2238448B1 (de) 2008-01-07 2016-04-06 Ortho-Clinical Diagnostics, Inc. Kalibrator/steuerung für simultanen test von untereinander komplexierungsfähigen proteinen
US8835183B2 (en) * 2008-01-07 2014-09-16 Ortho-Clinical Diagnostics, Inc. Determination of sFlt-1:angiogenic factor complex
US8741287B2 (en) 2008-06-18 2014-06-03 Abbott Laboratories PlGF-1 assay and kits and components thereof
US20100004306A1 (en) * 2008-06-18 2010-01-07 Abbott Laboratories PIGF-1 Assay and kits and components thereof
CN102224422A (zh) * 2008-11-20 2011-10-19 珀金埃尔默健康科学公司 使用pigf-2和pigf-3标志物确定先兆子痫风险的方法
US20100330703A1 (en) * 2009-06-24 2010-12-30 Seventh Sense Biosystems, Inc. Assays involving colorimetric and other signaling
JP6034394B2 (ja) * 2011-11-09 2016-11-30 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 切迫妊娠高血圧腎症および／またはＨＥＬＬＰ症候群の指標としてのｓＦｌｔ−１またはエンドグリン／ＰｌＧＦ比の動態
BR112014029233A8 (pt) 2012-06-27 2019-01-29 Hoffmann La Roche método para diagnosticar se um indivíduo grávido não está em risco, usos de pelo menos um dos biomarcadores sfit-1, endoglina e pigf, dispositivo, kit, método de gestão de um indivíduo, sistema e método para estabelecer um auxílio
ES2955883T3 (es) 2015-06-19 2023-12-07 Sera Prognostics Inc Pares de biomarcadores para la predicción del parto prematuro
KR20180117649A (ko) 2016-02-29 2018-10-29 에프. 호프만-라 로슈 아게 자간전증의 마커로서의 igfbp-7
AU2018317902B2 (en) 2017-08-18 2025-02-20 Sera Prognostics, Inc. Pregnancy clock proteins for predicting due date and time to birth
US20200264188A1 (en) 2017-09-13 2020-08-20 Progenity, Inc. Preeclampsia biomarkers and related systems and methods
EP4070113A4 (de) 2019-12-04 2023-12-20 Biora Therapeutics, Inc. Beurteilung von präeklampsie unter verwendung von tests für freien und dissoziierten plazentalen wachstumsfaktor

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0114528A3 (de) * 1982-12-27 1986-05-14 Trustees Of Boston University Abscheidung von Zellen auf Platten unter Verwendung von Nicht-Antikörperliganden
US5171695A (en) * 1986-08-06 1992-12-15 Multilyte Limited Determination of analyte concentration using two labelling markers
ZA9711456B (en) * 1996-12-20 1998-06-30 Ludwig Inst Cancer Res VEGF-B/receptor complex and uses thereof.
WO2000026674A1 (en) * 1998-10-30 2000-05-11 Merska B.V. Screening for analytes using labeled receptors
EP1239869B1 (de) * 1999-12-20 2013-08-28 Immunex Corporation Tweak rezeptor
WO2002099421A2 (en) * 2001-05-18 2002-12-12 Thomas Jefferson University Specific microarrays for breast cancer screening
CN1332978C (zh) * 2001-09-12 2007-08-22 北京市肿瘤防治研究所 作为VEGF受体Flt－1拮抗剂的肽
AU2002348289A1 (en) * 2001-11-19 2003-06-10 Protometrix, Inc. Method of using a non-antibody protein to detect and measure an analyte
US7435419B2 (en) * 2002-07-19 2008-10-14 Beth Israel Deaconess Medical Center Methods of diagnosing and treating pre-eclampsia or eclampsia
BRPI0312818B8 (pt) * 2002-07-19 2021-05-25 Beth Israel Deaconess Medical Ct Inc uso de uma medida do nível do polipeptídeo sflt-1 em uma amostra de uma paciente e uso de uma medida dos níveis de pelo menos dois dos peptídeos sflt1, vegf livre ou polipeptídio pigf livre em uma amostra de um paciente usando um métrico
WO2005017192A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
AU2004276791B2 (en) * 2003-09-23 2010-07-01 Beth Israel Deaconess Medical Center Screening for gestational disorders
EP1530047A1 (de) * 2003-11-07 2005-05-11 Roche Diagnostics GmbH Proximale Markermoleküle der Arterienthrombose und der Entzündung zur Risikostratifizierung einer koronaren Herzkrankheit
EP1615035B1 (de) * 2004-07-07 2007-06-06 F.Hoffmann-La Roche Ag Kombinationen von Markern zum Nachweis von typ 1 und 2 Diabetes
ATE519109T1 (de) * 2004-12-21 2011-08-15 Univ Yale Präeklampsie-diagnose

Also Published As

Publication number Publication date
JP5225097B2 (ja) 2013-07-03
WO2007059065B1 (en) 2007-09-13
ES2363609T3 (es) 2011-08-10
DE602006021777D1 (de) 2011-06-16
US20070111326A1 (en) 2007-05-17
CA2629451A1 (en) 2007-05-24
EP1952156A2 (de) 2008-08-06
JP2009516170A (ja) 2009-04-16
WO2007059065A3 (en) 2007-07-26
EP1952156B1 (de) 2011-05-04
WO2007059065A2 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
DE602006021777D1 (de) Diagnoseverfahren für präeklampsie
WO2006126008A3 (en) Improved immunoassay methods
ATE538386T1 (de) Nachweis von krebs anhand von erhöhten bcl-2- konzentrationen
NZ600828A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
TW200617380A (en) Concentration determination in a diffusion barrier layer
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
IL157380A0 (en) Mediator stabilized reagent compositions and methods for their use in electrochemical analyte detection assays
MX2009006205A (es) Inmunoensayo de multiples analitos.
BRPI0812875A2 (pt) " método pra identificar se ou não um indivíduo está sob risco de desenvolvimento de sépsis severa, anticorpo específico para proteína ligante de heparina, método pra reduzir o risco de um indivíduo desenvolver sépsis severa, e, kit de teste ".
ATE474228T1 (de) Reagenz für hämoglobinabbau
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
ATE395812T1 (de) Methoden zur vorhersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests
TW200613729A (en) Diagnostic test strip for collecting and detecting an analyte in a fluid sample and method for using same
PE20120592A1 (es) Metodo con biomarcadores para el seguimiento de un tratamiento
EP1476757A4 (de) Verfahren und kit zur krebsvorhersage
CY1109461T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
ATE549417T1 (de) Diagnoseverfahren für osteoarthritis
McKiernan et al. NextGen serology: leveraging mass spectrometry for Protein-Based human body fluid identification
SI1977244T1 (sl) Razlikovanje med bakterijskim meningitisom in virusnim meningitisom
WO2008035204A3 (en) Prediction and prophylactic treatment of type 1 diabetes
BRPI0618435A2 (pt) composição reagente de sensor teste tendo polìmeros de celulose adaptada para auxiliar na determinação de uma concentração de analito de uma amostra fluida, bem como processo de determinação de uma concentração de analito de uma amostra fluida
Slocombe et al. A method for determining the concentration of haptoglobin in cattle blood following haemolysis caused at collection
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
CA2586654A1 (en) Use of asc as a marker for colorectal cancer
WO2022229421A3 (en) Strem1 marker panels for early detection of sepsis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties